Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 9
2022 14
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.
Liu H, D'Alesio M, AlMasri S, Hammad A, Desilva A, Lebowitz S, Rieser C, Ashwat E, Hampton E, Khachfe H, Laffey M, Singhi A, Bahary N, Lee K, Zureikat A, Paniccia A. Liu H, et al. Among authors: almasri s. HPB (Oxford). 2023 May;25(5):521-532. doi: 10.1016/j.hpb.2023.01.016. Epub 2023 Feb 3. HPB (Oxford). 2023. PMID: 36804826
Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy.
Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A. Hammad AY, et al. Among authors: almasri s. JAMA Surg. 2023 Jan 1;158(1):55-62. doi: 10.1001/jamasurg.2022.5696. JAMA Surg. 2023. PMID: 36416848 Free PMC article.
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma.
AlMasri SS, Zenati MS, Desilva A, Nassour I, Boone BA, Singhi AD, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Paniccia A, Zeh HJ 3rd, Zureikat AH, Bahary N. AlMasri SS, et al. Cancer Med. 2021 Oct;10(20):7233-7241. doi: 10.1002/cam4.4211. Epub 2021 Sep 24. Cancer Med. 2021. PMID: 34559451 Free PMC article. Review.
Adaptive Dynamic Therapy and Survivorship for Operable Pancreatic Cancer.
AlMasri S, Zenati M, Hammad A, Nassour I, Liu H, Hogg ME, Zeh HJ, Boone B, Bahary N, Singhi AD, Lee KK, Paniccia A, Zureikat AH. AlMasri S, et al. JAMA Netw Open. 2022 Jun 1;5(6):e2218355. doi: 10.1001/jamanetworkopen.2022.18355. JAMA Netw Open. 2022. PMID: 35737385 Free PMC article.
Significance of Uncinate Duct Dilatation in IPMNs: A New High-risk Criterion?
AlMasri SS, Zenati MS, Dasyam A, Singhi AD, Lee KK, Bartlett DL, Slivka A, Mcgrath K, Chennat J, Fasanella KE, Khalid A, Brand RE, Sarkaria S, Das R, Hogg ME, Zeh HJ, Paniccia A, Zureikat AH. AlMasri SS, et al. Ann Surg. 2022 Jun 1;275(6):e789-e795. doi: 10.1097/SLA.0000000000004307. Epub 2020 Nov 12. Ann Surg. 2022. PMID: 33201115
28 results